Blaustein, Germany

Bettina Von Neubeck


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Bettina Von Neubeck: Pioneering Advances in Cancer Treatment

Introduction: Bettina Von Neubeck, a talented inventor based in Blaustein, Germany, is at the forefront of biotechnological innovation. With a focus on developing critical therapeutic agents, she has made significant contributions to the field of cancer research.

Latest Patents: Bettina holds a patent for an Anti-CD73 monoclonal antibody, encoding nucleic acids, and methods for producing it. This invention presents improved anti-CD73 antibodies that specifically target a membrane-bound form of the CD73 protein associated with cancer promotion while preserving the activity of the soluble form that provides cardioprotection. The innovation emphasizes the generation of specific anti-CD73 antibodies and their application as medicaments for cancer treatment, prophylaxis, and diagnostics.

Career Highlights: Bettina is currently affiliated with the Helmholtz Zentrum München, a leading research institution in the fields of health and environment. Her work at this prestigious center enables her to apply her innovative ideas towards enhancing cancer treatments and patient outcomes through cutting-edge research.

Collaborations: Throughout her career, Bettina has collaborated with esteemed colleagues, including Reinhard Zeidler and Regina Feederle. These partnerships have contributed to advancing their shared goals of developing effective medical solutions.

Conclusion: Bettina Von Neubeck's innovative work in the realm of anti-CD73 antibodies exemplifies her commitment to addressing significant medical challenges in cancer treatment. Her pioneering contributions reflect the vital role of inventors in pushing the boundaries of science and improving health outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…